Results 151 to 160 of about 11,405 (213)

Carbonic anhydrase 9 as a circulating biomarker and therapeutic target in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab. [PDF]

open access: yesJ Immunother Cancer
Sato Y   +27 more
europepmc   +1 more source

Incidence, Clinical Characteristics and Outcomes of Severe Prosthesis-Patient Mismatch in Patients Undergoing TAVI with Large Aortic Annuli. [PDF]

open access: yesMedicina (Kaunas)
Ali M   +9 more
europepmc   +1 more source

Systemic immune profiling uncovers divergent mechanisms and predictive biomarkers of response to combination immunotherapies in hepatocellular carcinoma. [PDF]

open access: yesJ Immunother Cancer
Nishio A   +20 more
europepmc   +1 more source

Bacterial Extracellular Vesicles: New Hype or Hope to Explain Reproductive Host-Microbiota Interactions. [PDF]

open access: yesJ Extracell Vesicles
Wein H   +5 more
europepmc   +1 more source

Phase II study of maintenance trifluridine/tipiracil (TAS-102) plus bevacizumab after induction chemotherapy in metastatic colorectal cancer. [PDF]

open access: yesOncologist
Ota K   +37 more
europepmc   +1 more source

Conversion Liver Resection for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus after Single Tremelimumab Regular Interval Durvalumab Regimen as a Second-Line Therapy: A Case Report. [PDF]

open access: yesSurg Case Rep
Akhmet D   +14 more
europepmc   +1 more source

Metastasis of Hepatocellular Carcinoma to the Urinary Bladder: A Case Report and Literature Review. [PDF]

open access: yesIJU Case Rep
Fukagawa E   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy